Andrew Pickering (he/him/his)

Ph.D. Candidate
Massachusetts Institute of Technology
Cambridge, Massachusetts, United States

Andrew Pickering is a graduate student in Professor Paula Hammond’s lab at MIT's Koch Institute for Integrative Cancer Research. His research focuses on the design of drug nanocarriers for targeted cancer therapy, with an emphasis on treating brain tumours such as glioblastoma. Specific research interests include the local delivery of nanocarriers containing targeted chemotherapies and nucleic acids.

Presentation(s):

• Harnessing Layer-by-Layer Assembly for Enhanced Nanoparticle Penetration and Glioblastoma Targeting in the Brain

  Thursday, October 12, 2023
  8:30 AM – 8:45 AM PDT

• Core material and surface chemistry of Layer-by-Layer (LbL) nanoparticles independently direct uptake, transport, and trafficking in preclinical blood-brain barrier (BBB) models

  Thursday, October 12, 2023
  12:55 PM – 1:00 PM PDT

• Dual targeted, layer-by-layer (LbL) electrostatically assembled nanoparticles cross the blood brain barrier to treat glioblastoma brain tumors

  Thursday, October 12, 2023
  1:00 PM – 1:05 PM PDT